Multidrug-resistant tuberculosis—can the tide be turned?
- 1 October 2001
- journal article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 1 (3) , 199-202
- https://doi.org/10.1016/s1473-3099(01)00096-2
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Prospects for better tuberculosis vaccinesThe Lancet Infectious Diseases, 2001
- Global Trends in Resistance to Antituberculosis DrugsNew England Journal of Medicine, 2001
- Tuberculosis at the end of the 20th century in England and Wales: results of a national survey in 1998Thorax, 2001
- Resource implications of patients with multidrug resistant tuberculosisThorax, 2000
- Criteria for the control of drug-resistant tuberculosisProceedings of the National Academy of Sciences, 2000
- Global Burden of TuberculosisJAMA, 1999
- Treatment and Prevention of Multidrug-Resistant TuberculosisDrugs, 1999
- Community based approaches to the control of multidrug resistant tuberculosis: introducing "DOTS-plus"BMJ, 1998
- Global Surveillance for Antituberculosis-Drug Resistance, 1994–1997New England Journal of Medicine, 1998
- Vaccination Against Tuberculosis: Past Problems and Future HopesSeminars in Respiratory and Critical Care Medicine, 1997